Buy Immunomedics Stock | IMMU Stock Price & Latest News | Public
IMMU

Immunomedics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About IMMU

    Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered i...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.15
    -0.29
    -0.44
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.26

    Actual EPS
    Q4 2020

    Stats

    Market Cap$20,3B
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$87.93
    1 Year Low$8.80
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app